
Patrick M. Fernandes
Examiner (ID: 8787, Phone: (571)272-7706 , Office: P/3736 )
| Most Active Art Unit | 3791 |
| Art Unit(s) | 3736, 3791 |
| Total Applications | 613 |
| Issued Applications | 344 |
| Pending Applications | 74 |
| Abandoned Applications | 222 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17673120
[patent_doc_number] => 20220186287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => NOVEL LUCIFERASE SEQUENCES UTILIZING INFRARED-EMITTING SUBSTRATES TO PRODUCE ENHANCED LUMINESCENCE
[patent_app_type] => utility
[patent_app_number] => 17/683939
[patent_app_country] => US
[patent_app_date] => 2022-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27865
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17683939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/683939 | Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence | Feb 28, 2022 | Issued |
Array
(
[id] => 19573118
[patent_doc_number] => 20240377410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => METHODS FOR THE MEASUREMENT OF PROTEIN C AND ACTIVATED PROTEIN C
[patent_app_type] => utility
[patent_app_number] => 18/548043
[patent_app_country] => US
[patent_app_date] => 2022-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14106
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548043
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548043 | METHODS FOR THE MEASUREMENT OF PROTEIN C AND ACTIVATED PROTEIN C | Feb 28, 2022 | Pending |
Array
(
[id] => 19573118
[patent_doc_number] => 20240377410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => METHODS FOR THE MEASUREMENT OF PROTEIN C AND ACTIVATED PROTEIN C
[patent_app_type] => utility
[patent_app_number] => 18/548043
[patent_app_country] => US
[patent_app_date] => 2022-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14106
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548043
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548043 | METHODS FOR THE MEASUREMENT OF PROTEIN C AND ACTIVATED PROTEIN C | Feb 28, 2022 | Pending |
Array
(
[id] => 17642376
[patent_doc_number] => 20220170114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => BIOMARKERS OF CHRONIC LYMPHOCYTIC LEUKEMIA AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/673329
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13889
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673329
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/673329 | BIOMARKERS OF CHRONIC LYMPHOCYTIC LEUKEMIA AND USE THEREOF | Feb 15, 2022 | Abandoned |
Array
(
[id] => 20116882
[patent_doc_number] => 12366582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-22
[patent_title] => Collagen type X alpha-1 assay
[patent_app_type] => utility
[patent_app_number] => 17/584517
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 2509
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584517
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/584517 | Collagen type X alpha-1 assay | Jan 25, 2022 | Issued |
Array
(
[id] => 17580213
[patent_doc_number] => 20220137068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => S100A8 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS
[patent_app_type] => utility
[patent_app_number] => 17/575176
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17575176
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/575176 | S100A8 AS BLOOD BIOMARKER FOR THE NON-INVASIVE DIAGNOSIS OF ENDOMETRIOSIS | Jan 12, 2022 | Pending |
Array
(
[id] => 17564418
[patent_doc_number] => 20220128567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => EX VIVO PROTEASE ACTIVITY DETECTION FOR DISEASE DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/573123
[patent_app_country] => US
[patent_app_date] => 2022-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31931
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17573123
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/573123 | Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment | Jan 10, 2022 | Issued |
Array
(
[id] => 17521470
[patent_doc_number] => 20220107319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => SYSTEMS AND METHODS FOR THE MOLECULAR QUANTIFICATION OF SKIN DAMAGE IN SKIN
[patent_app_type] => utility
[patent_app_number] => 17/551112
[patent_app_country] => US
[patent_app_date] => 2021-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551112
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/551112 | SYSTEMS AND METHODS FOR THE MOLECULAR QUANTIFICATION OF SKIN DAMAGE IN SKIN | Dec 13, 2021 | Abandoned |
Array
(
[id] => 17521465
[patent_doc_number] => 20220107314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => IMMUNOASSAY CONTROLS AND THE USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/549725
[patent_app_country] => US
[patent_app_date] => 2021-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17549725
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/549725 | Immunoassay controls and the use thereof | Dec 12, 2021 | Issued |
Array
(
[id] => 17674126
[patent_doc_number] => 20220187293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => SYSTEMS AND METHODS FOR RHEUMATOID ARTHRITIS BIOMARKER DETECTION
[patent_app_type] => utility
[patent_app_number] => 17/548221
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11361
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17548221
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/548221 | Systems and methods for rheumatoid arthritis biomarker detection | Dec 9, 2021 | Issued |
Array
(
[id] => 17613006
[patent_doc_number] => 20220155286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => HIGH THROUGHPUT DRUG SCREENING METHODS
[patent_app_type] => utility
[patent_app_number] => 17/529157
[patent_app_country] => US
[patent_app_date] => 2021-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -71
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17529157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/529157 | High throughput drug screening methods | Nov 16, 2021 | Issued |
Array
(
[id] => 17613006
[patent_doc_number] => 20220155286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => HIGH THROUGHPUT DRUG SCREENING METHODS
[patent_app_type] => utility
[patent_app_number] => 17/529157
[patent_app_country] => US
[patent_app_date] => 2021-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -71
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17529157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/529157 | High throughput drug screening methods | Nov 16, 2021 | Issued |
Array
(
[id] => 17445368
[patent_doc_number] => 20220065873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => Antibodies and Methods for the Detection of Cell Death
[patent_app_type] => utility
[patent_app_number] => 17/526941
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7851
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17526941
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/526941 | Antibodies and Methods for the Detection of Cell Death | Nov 14, 2021 | Abandoned |
Array
(
[id] => 18826092
[patent_doc_number] => 11841364
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-12
[patent_title] => Method for acquiring information on respiratory infection
[patent_app_type] => utility
[patent_app_number] => 17/507867
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 25
[patent_no_of_words] => 17590
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17507867
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/507867 | Method for acquiring information on respiratory infection | Oct 21, 2021 | Issued |
Array
(
[id] => 20108555
[patent_doc_number] => 12359264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => Co-binder assisted assay methods
[patent_app_type] => utility
[patent_app_number] => 17/504937
[patent_app_country] => US
[patent_app_date] => 2021-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3213
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17504937
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/504937 | Co-binder assisted assay methods | Oct 18, 2021 | Issued |
Array
(
[id] => 17387045
[patent_doc_number] => 20220034897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => ASSAYS FOR DETECTING MODIFIED COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/501143
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501143
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/501143 | Assays for detecting modified compounds | Oct 13, 2021 | Issued |
Array
(
[id] => 17371361
[patent_doc_number] => 20220026413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => Biosensor for Male Infertility
[patent_app_type] => utility
[patent_app_number] => 17/492331
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17492331
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/492331 | Biosensor for male infertility | Sep 30, 2021 | Issued |
| 17/492372 | METHOD FOR DETERMINING A CONCENTRATION OF N-TERMINAL PRO-HORMONE BNP (NT-PROBNP) IN A SAMPLE | Sep 30, 2021 | |
Array
(
[id] => 17344991
[patent_doc_number] => 20220011322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => METHOD AND KIT FOR THE DETECTION OF PANCREATIC DYSFUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/487089
[patent_app_country] => US
[patent_app_date] => 2021-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19043
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17487089
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/487089 | Method and kit for the detection of pancreatic dysfunction | Sep 27, 2021 | Issued |
Array
(
[id] => 18719203
[patent_doc_number] => 11796541
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Methods for assessing mucosal healing in ulcerative colitis disease patients
[patent_app_type] => utility
[patent_app_number] => 17/483462
[patent_app_country] => US
[patent_app_date] => 2021-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 14
[patent_no_of_words] => 14648
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17483462
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/483462 | Methods for assessing mucosal healing in ulcerative colitis disease patients | Sep 22, 2021 | Issued |